Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Software AG

Start price
Target price
Perf. (%)
€36.48
19.10.21
-
19.10.22
-0.88%
13.11.21

Could be worthwhile Investment >10% per year
buy
Patrizia Immobilien AG

Start price
Target price
Perf. (%)
€21.55
10.05.21
€26.00
10.11.21
7.66%
10.11.21

Normal challenges to pay loans and raise capital
Could be very worthwhile Investment >20% year
High dividend yield expected
Small Risks for its business
buy
Schaeffler AG

Start price
Target price
Perf. (%)
€5.55
04.11.20
€7.90
04.11.21
25.95%
05.11.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Südzucker AG

Start price
Target price
Perf. (%)
€17.09
16.09.20
€40.00
04.11.21
-18.67%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Rising EBIT margin expected
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€108.25
06.08.20
€130.00
04.11.21
-62.47%
05.11.21

buy
Fielmann AG

Start price
Target price
Perf. (%)
€65.20
14.07.20
-
04.11.21
-6.90%
05.11.21

Patrizia Immobilien AG

Start price
Target price
Perf. (%)
€19.00
25.03.20
-
04.11.21
21.84%
05.11.21

buy
Metro AG ST

Start price
Target price
Perf. (%)
€7.04
24.03.20
-
04.11.21
59.23%
05.11.21

buy
Grenke AG

Start price
Target price
Perf. (%)
€54.20
24.03.20
-
04.11.21
-37.82%
05.11.21

buy
1&1 Drillisch AG

Start price
Target price
Perf. (%)
€16.69
19.03.20
€29.00
04.11.21
54.46%
05.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€40.55
17.03.20
€180.00
04.11.21
268.43%
05.11.21

Could be worthwhile Investment >10% per year
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€106.70
25.02.20
€61.00
04.11.21
-61.92%
05.11.21

positive Cash Flow expected
Good rating
High Investments for future growth
High valuation
buy
Software AG

Start price
Target price
Perf. (%)
€30.95
04.02.20
-
04.11.21
17.22%
05.11.21

buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€36.50
15.10.19
€50.00
04.11.21
309.32%
05.11.21

buy
Schaeffler AG

Start price
Target price
Perf. (%)
€13.61
06.02.18
€16.00
04.11.21
-48.62%
05.11.21

buy
MorphoSys AG

Start price
Target price
Perf. (%)
€47.81
30.08.21
€53.00
30.08.22
5.67%
04.09.21

Could be worthwhile Investment >10% per year
Innovative
Top 10 in its market
Higher risks for its business
buy
Software AG

Start price
Target price
Perf. (%)
€40.00
23.09.18
€43.50
04.11.21
-4.45%
22.06.21

buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€219.50
22.02.21
-
22.02.22
-28.06%
14.06.21

AUTO1 Group SE

Start price
Target price
Perf. (%)
€6.07
22.04.21
-
-
22.04.21

Could be worthwhile Investment >10% per year
Medium risks for its business
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€152.40
06.01.21
€200.00
16.80%
30.03.21

Medium risks for its business
buy
AUTO1 Group SE

Start price
Target price
Perf. (%)
€49.74
22.03.21
€55.00
-1.23%
23.03.21

Could be worthwhile Investment >10% per year
Medium risks for its business
buy
Grenke AG

Start price
Target price
Perf. (%)
€34.18
19.09.20
-
04.11.21
-3.10%
11.03.21

Could be worthwhile Investment >10% per year
Grenke AG

Start price
Target price
Perf. (%)
€29.60
08.02.21
€20.00
08.02.22
1.76%
22.02.21

Some uniques
Probably not worthwhile Investment
Deficits in Management
Very bad culture
buy
Schaeffler AG

Start price
Target price
Perf. (%)
€6.47
19.08.20
€6.90
04.11.21
2.16%
02.02.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Innovative
buy
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€191.40
21.01.21
€200.00
4.49%
26.01.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Very positive Cash Flow expected